Zimbroff Dan L
Pacific Clinical Research Medical Group, Upland, California, USA.
CNS Drugs. 2008;22(3):199-212. doi: 10.2165/00023210-200822030-00002.
Acute agitation in the psychiatric emergency setting is a common presentation, which can endanger the patient, caregivers and professional staff. Rapid and effective treatment, followed by ongoing evaluation and maintenance treatment where appropriate, is key to circumvent negative outcomes. Nonpharmacological measures are the first step in treating the acutely agitated patient, and include verbal intervention and physical restraint. Pharmacological treatment is often required to ensure the safety of the patient, caregivers and the treatment team. The need for drug delivery in uncooperative patients favours the use of intramuscular preparations for the acutely agitated patient. Intramuscular treatment options include benzodiazepines, conventional antipsychotics and atypical antipsychotics. Each of these medications offers a unique pharmacological profile that must be considered when treating acutely agitated patients, who may be unwilling or unable to accurately communicate their co-morbid conditions and concomitant medications.
在精神科急诊环境中,急性激越状态是一种常见表现,它可能危及患者、护理人员及专业工作人员。迅速且有效的治疗,随后在适当情况下进行持续评估和维持治疗,是避免不良后果的关键。非药物措施是治疗急性激越患者的第一步,包括言语干预和身体约束。通常需要药物治疗以确保患者、护理人员及治疗团队的安全。对于不合作的患者,药物给药的需求使得肌肉注射制剂适用于急性激越患者。肌肉注射治疗选择包括苯二氮䓬类药物、传统抗精神病药物和非典型抗精神病药物。在治疗急性激越患者时,必须考虑这些药物各自独特的药理学特性,因为这些患者可能不愿意或无法准确告知其共病情况和正在服用的药物。